Published in Ann Surg Oncol on June 26, 2012
Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg (2013) 1.27
TiLoop® Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series. Eur J Plast Surg (2014) 0.94
Use of prophylactic postoperative antibiotics during surgical drain presence following mastectomy. Ann Surg Oncol (2014) 0.83
Should a drain be placed in early breast cancer surgery? Breast Care (Basel) (2014) 0.78
Flap fixation reduces seroma in patients undergoing mastectomy: a significant implication for clinical practice. World J Surg Oncol (2016) 0.78
Subcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results. Plast Reconstr Surg Glob Open (2016) 0.78
Prophylactic Antibiotic Choice and Risk of Surgical Site Infection After Hysterectomy. Obstet Gynecol (2016) 0.78
Does Non-Placement of a Drain in Breast Surgery Increase the Rate of Complications and Revisions? Geburtshilfe Frauenheilkd (2013) 0.77
National practice in antibiotic prophylaxis in breast cancer surgery. J Clin Med Res (2013) 0.76
Antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial. Trials (2016) 0.75
A study on surgical site infections after trauma surgeries in a tertiary care hospital in north India. Indian J Med Res (2014) 0.75
Surgical site infection complicating breast cancer surgery in kuwait. ISRN Prev Med (2012) 0.75
The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters. Ann Surg Oncol (2017) 0.75
Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open (2017) 0.75
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control (1999) 8.64
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst (2006) 7.29
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol (2007) 4.05
National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control (2009) 3.91
Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg (2003) 1.61
Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg (2009) 1.39
Surgical site infections in breast surgery: case-control study. World J Surg (2004) 1.34
Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg (2008) 1.23
Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J (2004) 1.21
Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer (2007) 1.10
Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol (2006) 1.09
Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg (1999) 1.05
Determinants of surgical site infection after breast biopsy. Am J Infect Control (2005) 0.99
Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: A case-control analysis. Breast Cancer Res Treat (2005) 0.96
Breast cancer surgery in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg (2007) 0.94
Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg (2009) 0.91
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation (2012) 5.25
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol (2009) 4.13
An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis (2003) 3.93
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol (2007) 3.16
Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines. Circulation (2012) 2.97
Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA (2005) 2.92
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation (2015) 2.84
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis (2010) 2.54
Fungal endocarditis, 1995-2000. Chest (2002) 2.52
A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis (2011) 2.50
The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis (2006) 2.37
Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19
Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med (2007) 2.14
Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol (2008) 2.06
Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med (2007) 2.03
A meta-analysis of patellar tendon autograft versus patellar tendon allograft in anterior cruciate ligament reconstruction. Arthroscopy (2007) 1.84
Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg (2004) 1.82
Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis (2010) 1.79
Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) (2007) 1.75
Common iliac artery aneurysm: expansion rate and results of open surgical and endovascular repair. J Vasc Surg (2008) 1.73
Avian influenza: a new pandemic threat? Mayo Clin Proc (2004) 1.67
Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis (2006) 1.66
Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging (2012) 1.66
Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis. Am J Med (2006) 1.63
Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc (2008) 1.61
Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol (2009) 1.60
Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg (2012) 1.59
A systematic review of population-based studies of infective endocarditis. Chest (2007) 1.59
Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis (2006) 1.58
Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet (2003) 1.58
Risk factor analysis of permanent pacemaker infection. Clin Infect Dis (2007) 1.51
Propensity score analysis with a time-dependent intervention is an acceptable although not an optimal analytical approach when treatment selection bias and survivor bias coexist. J Clin Epidemiol (2009) 1.51
Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol (2010) 1.50
Bronchoscopy in ventilator-associated pneumonia: agreement of calibrated loop and serial dilution. Am J Respir Crit Care Med (2006) 1.47
Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (2010) 1.45
Endovascular repair of abdominal aortic aneurysms: initial experience with 100 consecutive patients. Mayo Clin Proc (2003) 1.44
Feasibility of using a walking workstation during CT image interpretation. J Am Coll Radiol (2008) 1.41
Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace (2012) 1.40
The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis (2013) 1.36
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc (2007) 1.34
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. Clin Cancer Res (2012) 1.33
Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses (2010) 1.31
Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect (2005) 1.31
In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol (2006) 1.30
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28
Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med (2008) 1.28
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother (2009) 1.27
Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg (2013) 1.27
Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J (2008) 1.26
CT of small-bowel ischemia associated with obstruction in emergency department patients: diagnostic performance evaluation. Radiology (2006) 1.23
Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol (2009) 1.23
Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg (2008) 1.23
Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg (2009) 1.21
An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol (2012) 1.21
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol (2010) 1.21
Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol (2012) 1.20
Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc (2012) 1.18
Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm (2011) 1.15
Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial. Cancer Control (2012) 1.12
Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011: The Devil Is in the Details. J Am Coll Cardiol (2015) 1.12
Pacemaker infection due to Mycobacterium fortuitum. Scand J Infect Dis (2005) 1.12
Cutaneous inoculation blastomycosis. Clin Infect Dis (2002) 1.11
Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother (2009) 1.10
Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis (2003) 1.10
Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis (2013) 1.10
Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg (2012) 1.10
The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation (2007) 1.09
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis (2009) 1.09
Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc (2010) 1.08
Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis (2007) 1.08
Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One (2012) 1.08
The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J (2008) 1.07
Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol (2011) 1.07
Early cardiac surgery after ischemic stroke in patients with infective endocarditis may not be safe. Clin Infect Dis (2013) 1.07
Open repair of juxtarenal aortic aneurysms (JAA) remains a safe option in the era of fenestrated endografts. J Vasc Surg (2008) 1.07
Sclerotherapy for the treatment of postmastectomy seroma. Am J Surg (2008) 1.07
Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis (2009) 1.06
Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother (2004) 1.05
Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol (2009) 1.05
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol (2011) 1.05